BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Olavarria E, Child F, Woolford A, Whittaker SJ, Davis JG, McDonald C, Chilcott S, Spittle M, Grieve RJ, Stewart S. T-cell depletion and autologous stem cell transplantation in the management of tumour stage mycosis fungoides with peripheral blood involvement. Br J Haematol. 2001;114:624-631. [PMID: 11552988 DOI: 10.1046/j.1365-2141.2001.02919.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Lee YP, Yoon SE, Song Y, Kim SJ, Yoon DH, Chen TY, Koh YI, Kang KW, Lee HS, Wei KTK, Lim ST, Poon M, Irawan C, Zhao W, Do YR, Lee MH, Ng SC, Lee WS, Guo Y, Zhang H, Kang HJ, Yun HJ, Kim HJ, Lung DTC, Kwak JY, Han JJ, Mun YC, Oh SY, Shim H, Kwon JH, Sohn BS, Park SK, Jo JC, Ko YH, Jun Z, Kim WS. Cutaneous T-cell lymphoma in Asian patients: a multinational, multicenter, prospective registry study in Asia. Int J Hematol 2021;114:355-62. [PMID: 34302593 DOI: 10.1007/s12185-021-03179-7] [Reference Citation Analysis]
2 Kamijo H, Miyagaki T. Mycosis Fungoides and Sézary Syndrome: Updates and Review of Current Therapy. Curr Treat Options Oncol 2021;22:10. [PMID: 33415447 DOI: 10.1007/s11864-020-00809-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
3 Querfeld C, Rosen ST, Duvic M. Cutaneous T-Cell Lymphoma and Cutaneous B-Cell Lymphoma. Abeloff's Clinical Oncology 2020. [DOI: 10.1016/b978-0-323-47674-4.00104-3] [Reference Citation Analysis]
4 Doerschner M, Pekar-Lukacs A, Messerli-Odermatt O, Dommann-Scherrer C, Rütti M, Müller AM, Nair G, Kamarachev J, Kerl K, Beer M, Messerli M, Frauenknecht K, Haralambieva E, Hoetzenecker W, French LE, Guenova E. Interferon alfa-2a maintenance after salvage autologous stem cell transplantation in atypical mycosis fungoides with central nervous system involvement. Br J Dermatol 2019;181:1296-302. [PMID: 30565216 DOI: 10.1111/bjd.17535] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
5 Zain J. Transplantation. Cancer Treatment and Research 2019. [DOI: 10.1007/978-3-319-99716-2_13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
6 Gilson D, Whittaker S, Child F, Scarisbrick J, Illidge T, Parry E, Mohd Mustapa M, Exton L, Kanfer E, Rezvani K, Dearden C, Morris S, Mchenry P, Leslie T, Wakelin S, Hunasehally R, Cork M, Johnston G, Chiang N, Worsnop F, Salim A, Buckley D, Petrof G, Callachand N, Flavell T, Salad A. British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous lymphomas 2018. Br J Dermatol 2019;180:496-526. [DOI: 10.1111/bjd.17240] [Cited by in Crossref: 68] [Cited by in F6Publishing: 71] [Article Influence: 13.6] [Reference Citation Analysis]
7 Chung CG, Poligone B, Heald PW. Cutaneous T-Cell Lymphoma. Biologic and Systemic Agents in Dermatology 2018. [DOI: 10.1007/978-3-319-66884-0_33] [Reference Citation Analysis]
8 Stephen S, Kim EJ, Introcaso CE, Richardson SK, Rook AH. Cutaneous T-Cell Lymphoma. In: Gaspari AA, Tyring SK, Kaplan DH, editors. Clinical and Basic Immunodermatology. Cham: Springer International Publishing; 2017. pp. 715-40. [DOI: 10.1007/978-3-319-29785-9_41] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
9 Hoppe RT, Kim YH, Advani RH. Mycosis Fungoides and Sézary Syndrome. Holland-Frei Cancer Medicine 2017. [DOI: 10.1002/9781119000822.hfcm121] [Reference Citation Analysis]
10 Patir P, Vural F. Treatment of mycosis fungoides, in the era of stem cell transplantation. World J Dermatol 2016; 5(1): 52-56 [DOI: 10.5314/wjd.v5.i1.52] [Reference Citation Analysis]
11 Zain J, Thomas SH. Hematopoietic Cell Transplantation for Non'Hodgkin Lymphoma (T Cell). Thomas’ Hematopoietic Cell Transplantation 2016. [DOI: 10.1002/9781118416426.ch58] [Reference Citation Analysis]
12 Pullarkat V, Forman SJ. Hematopoietic Cell Transplantation for Rare Hematologic Malignancies. Thomas’ Hematopoietic Cell Transplantation 2016. [DOI: 10.1002/9781118416426.ch67] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
13 Virmani P, Zain J, Rosen ST, Myskowski PL, Querfeld C. Hematopoietic Stem Cell Transplant for Mycosis Fungoides and Sézary Syndrome. Dermatologic Clinics 2015;33:807-18. [DOI: 10.1016/j.det.2015.05.014] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
14 Hosing C, Bassett R, Dabaja B, Talpur R, Alousi A, Ciurea S, Popat U, Qazilbash M, Shpall EJ, Oki Y, Nieto Y, Pinnix C, Fanale M, Maadani F, Donato M, Champlin R, Duvic M. Allogeneic stem-cell transplantation in patients with cutaneous lymphoma: updated results from a single institution. Ann Oncol 2015;26:2490-5. [PMID: 26416896 DOI: 10.1093/annonc/mdv473] [Cited by in Crossref: 67] [Cited by in F6Publishing: 69] [Article Influence: 8.4] [Reference Citation Analysis]
15 Jacobsen ED. Stem cell transplantation for mycosis fungoides/Sézary syndrome. Clinical Guide to Transplantation in Lymphoma 2015. [DOI: 10.1002/9781118863282.ch23] [Reference Citation Analysis]
16 Moriarty B, Whittaker S. Diagnosis, prognosis and management of erythrodermic cutaneous T-cell lymphoma. Expert Review of Hematology 2015;8:159-71. [DOI: 10.1586/17474086.2015.984681] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
17 Lechowicz MJ, Lazarus HM, Carreras J, Laport GG, Cutler CS, Wiernik PH, Hale GA, Maharaj D, Gale RP, Rowlings PA. Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndrome. Bone Marrow Transplant. 2014;49:1360-1365. [PMID: 25068422 DOI: 10.1038/bmt.2014.161] [Cited by in Crossref: 66] [Cited by in F6Publishing: 70] [Article Influence: 7.3] [Reference Citation Analysis]
18 Child F, Whittaker S. Primary Cutaneous T-cell Lymphoma. Evidence-Based Dermatology 2014. [DOI: 10.1002/9781118357606.ch34] [Reference Citation Analysis]
19 Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions. J Am Acad Dermatol. 2014;70:223.e1-217.e1; quiz 240-242. [PMID: 24438970 DOI: 10.1016/j.jaad.2013.08.033] [Cited by in Crossref: 188] [Cited by in F6Publishing: 206] [Article Influence: 20.9] [Reference Citation Analysis]
20 Zain J, Weichenthal M, Rodig S, Delabie J. Cutaneous T-Cell Lymphoma. Rare Lymphomas 2014. [DOI: 10.1007/978-3-642-39590-1_8] [Reference Citation Analysis]
21 Ortiz-romero PL, Papadavid E. Systemic Treatment of Primary Cutaneous Lymphomas. Skin Cancer 2014. [DOI: 10.1007/978-1-4614-7357-2_29] [Reference Citation Analysis]
22 Querfeld C, Rosen ST. Cutaneous T-Cell Lymphoma and Cutaneous B-Cell Lymphoma. Abeloff's Clinical Oncology 2014. [DOI: 10.1016/b978-1-4557-2865-7.00107-7] [Reference Citation Analysis]
23 Songdej N, Winer ES. Autologous Hematopoietic Stem Cell Transplantation in Non-Hodgkin Lymphomas. Non-Hodgkin Lymphoma 2013. [DOI: 10.1007/978-1-4614-5851-7_14] [Reference Citation Analysis]
24 Li JY, Horwitz S, Moskowitz A, Myskowski PL, Pulitzer M, Querfeld C. Management of cutaneous T cell lymphoma: new and emerging targets and treatment options. Cancer Manag Res 2012;4:75-89. [PMID: 22457602 DOI: 10.2147/CMAR.S9660] [Cited by in Crossref: 3] [Cited by in F6Publishing: 13] [Article Influence: 0.3] [Reference Citation Analysis]
25 Zain J, Palmer JM, Delioukina M, Thomas S, Tsai NC, Nademanee A, Popplewell L, Gaal K, Senitzer D, Kogut N, O'Donnell M, Forman SJ. Allogeneic hematopoietic cell transplant for peripheral T-cell non-Hodgkin lymphoma results in long-term disease control. Leuk Lymphoma 2011;52:1463-73. [PMID: 21699453 DOI: 10.3109/10428194.2011.574754] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
26 . Neoplasms. British Association of Dermatologists' Management Guidelines 2011. [DOI: 10.1002/9781444329865.ch3] [Reference Citation Analysis]
27 Olsen EA, Rook AH, Zic J, Kim Y, Porcu P, Querfeld C, Wood G, Demierre M, Pittelkow M, Wilson LD, Pinter-brown L, Advani R, Parker S, Kim EJ, Junkins-hopkins JM, Foss F, Cacchio P, Duvic M. Sézary syndrome: Immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC). Journal of the American Academy of Dermatology 2011;64:352-404. [DOI: 10.1016/j.jaad.2010.08.037] [Cited by in Crossref: 124] [Cited by in F6Publishing: 129] [Article Influence: 10.3] [Reference Citation Analysis]
28 Schmitz S. Von der Wichtigkeit wissenschaftsgetriebener Studien. Best Practice Onkologie 2010;5:1-1. [DOI: 10.1007/s11654-010-0251-z] [Reference Citation Analysis]
29 Devine SM. Hematopoietic stem cell transplantation for cutaneous T-cell lymphoma. Clin Lymphoma Myeloma Leuk 2010;10 Suppl 2:S96-8. [PMID: 20826408 DOI: 10.3816/CLML.2010.s.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
30 Lansigan F, Foss FM. Current and emerging treatment strategies for cutaneous T-cell lymphoma. Drugs 2010;70:273-86. [PMID: 20166766 DOI: 10.2165/11532190-000000000-00000] [Cited by in Crossref: 77] [Cited by in F6Publishing: 79] [Article Influence: 5.9] [Reference Citation Analysis]
31 Whittaker SJ. Cutaneous Lymphomas and Lymphocytic Infiltrates. Rook's Textbook of Dermatology 2010. [DOI: 10.1002/9781444317633.ch57] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
32 Duvic M, Donato M, Dabaja B, Richmond H, Singh L, Wei W, Acholonu S, Khouri I, Champlin R, Hosing C. Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sezary syndrome. J Clin Oncol. 2010;28:2365-2372. [PMID: 20351328 DOI: 10.1200/jco.2009.25.8301] [Cited by in Crossref: 118] [Cited by in F6Publishing: 124] [Article Influence: 9.1] [Reference Citation Analysis]
33 Hoppe RT, Advani R, Kim YH. Mycosis Fungoides. Leibel and Phillips Textbook of Radiation Oncology 2010. [DOI: 10.1016/b978-1-4160-5897-7.00064-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
34 Kirby JS, Kim EJ, Rook AH. Therapy of Sézary syndrome. Expert Review of Dermatology 2009;4:567-579. [DOI: 10.1586/edm.09.57] [Reference Citation Analysis]
35 Prince HM, Whittaker S, Hoppe RT. How I treat mycosis fungoides and Sézary syndrome. Blood 2009;114:4337-53. [DOI: 10.1182/blood-2009-07-202895] [Cited by in Crossref: 108] [Cited by in F6Publishing: 115] [Article Influence: 7.7] [Reference Citation Analysis]
36 Wu PA, Kim YH, Lavori PW, Hoppe RT, Stockerl-Goldstein KE. A meta-analysis of patients receiving allogeneic or autologous hematopoietic stem cell transplant in mycosis fungoides and Sézary syndrome. Biol Blood Marrow Transplant 2009;15:982-90. [PMID: 19589488 DOI: 10.1016/j.bbmt.2009.04.017] [Cited by in Crossref: 89] [Cited by in F6Publishing: 90] [Article Influence: 6.4] [Reference Citation Analysis]
37 Pichardo D, Querfeld C, Guitart J, Kuzel T, Rosen S. Cutaneous T-Cell Lymphoma: A Paradigm for Biological Therapies. Leukemia & Lymphoma 2009;45:1755-65. [DOI: 10.1080/10428190410001693560] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
38 Gardner JM, Evans KG, Musiek A, Rook AH, Kim EJ. Update on treatment of cutaneous T-cell lymphoma. Current Opinion in Oncology 2009;21:131-7. [DOI: 10.1097/cco.0b013e3283253190] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
39 Fukushima T, Horio K, Matsuo E, Imanishi D, Yamasaki R, Tsushima H, Imaizumi Y, Ohshima K, Hata T, Yoshida S, Miyazaki Y, Tomonaga M. Successful cord blood transplantation for mycosis fungoides. Int J Hematol 2008;88:596-8. [DOI: 10.1007/s12185-008-0190-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
40 Kim EJ, Introcaso CE, Richardson SK, Rook AH. Cutaneous T-Cell Lymphoma. Clinical and Basic Immunodermatology. [DOI: 10.1007/978-1-84800-165-7_25] [Reference Citation Analysis]
41 Cudillo L, Cerretti R, Baliva G, De Angelis G, Postorino M, Picardi A, Mirabile M, Lanti A, Cantonetti M, Arcese W; for the Rome Transplant Network. Sezary syndrome in relapse after reduced intensity allogeneic transplant successfully treated with donor lymphocyte infusion. Bone Marrow Transplant 2009;43:347-8. [DOI: 10.1038/bmt.2008.333] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
42 Lansigan F, Choi J, Foss FM. Cutaneous T-cell Lymphoma. Hematology/Oncology Clinics of North America 2008;22:979-96. [DOI: 10.1016/j.hoc.2008.07.014] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
43 Yoshimi A, Izutsu K, Takahashi M, Kako S, Oshima K, Kanda Y, Motokura T, Chiba S, Momose T, Ohtomo K, Kurokawa M. Conventional allogeneic hematopoietic stem cell transplantation for lymphoma may overcome the poor prognosis associated with a positive FDG-PET scan before transplantation. Am J Hematol 2008;83:477-81. [PMID: 18266206 DOI: 10.1002/ajh.21158] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
44 Introcaso CE, Leber B, Greene K, Ubriani R, Rook AH, Kim EJ. Stem cell transplantation in advanced cutaneous T-cell lymphoma. Journal of the American Academy of Dermatology 2008;58:645-9. [DOI: 10.1016/j.jaad.2007.12.021] [Cited by in Crossref: 27] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
45 Fink-puches R, Cerroni L. Cutaneous T-cell lymphoma and emerging therapies. Drug Discovery Today: Disease Mechanisms 2008;5:e69-e79. [DOI: 10.1016/j.ddmec.2008.09.010] [Reference Citation Analysis]
46 Duarte RF, Schmitz N, Servitje O, Sureda A. Haematopoietic stem cell transplantation for patients with primary cutaneous T-cell lymphoma. Bone Marrow Transplant. 2008;41:597-604. [PMID: 18176611 DOI: 10.1038/sj.bmt.1705968] [Cited by in Crossref: 90] [Cited by in F6Publishing: 93] [Article Influence: 6.0] [Reference Citation Analysis]
47 Habermann TM, Pittelkow MR. Cutaneous T-Cell Lymphoma and Cutaneous B-Cell Lymphoma. Abeloff's Clinical Oncology 2008. [DOI: 10.1016/b978-0-443-06694-8.50117-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
48 Zinzani PL, Ferreri AJ, Cerroni L. Mycosis fungoides. Crit Rev Oncol Hematol 2008;65:172-82. [PMID: 17950613 DOI: 10.1016/j.critrevonc.2007.08.004] [Cited by in Crossref: 55] [Cited by in F6Publishing: 61] [Article Influence: 3.4] [Reference Citation Analysis]
49 Gabriel IH, Olavarria E, Jones RR, Whittaker S, Chaidos A, Apperley JF. Graft versus lymphoma effect after early relapse following reduced-intensity sibling allogeneic stem cell transplantation for relapsed cytotoxic variant of mycosis fungoides. Bone Marrow Transplant 2007;40:401-3. [PMID: 17589536 DOI: 10.1038/sj.bmt.1705741] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
50 Whittaker SJ, Foss FM. Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphoma. Cancer Treat Rev. 2007;33:146-160. [PMID: 17275192 DOI: 10.1016/j.ctrv.2006.08.006] [Cited by in Crossref: 71] [Cited by in F6Publishing: 77] [Article Influence: 4.4] [Reference Citation Analysis]
51 Scarisbrick J. Treatment of mycosis fungoides and Sézary syndrome: recent advances and novel therapies. Expert Review of Dermatology 2006;1:569-577. [DOI: 10.1586/17469872.1.4.569] [Reference Citation Analysis]
52 Molina A, Zain J, Arber DA, Angelopolou M, O’donnell M, Murata-collins J, Forman SJ, Nademanee A. Durable Clinical, Cytogenetic, and Molecular Remissions After Allogeneic Hematopoietic Cell Transplantation for Refractory Sezary Syndrome and Mycosis Fungoides. JCO 2005;23:6163-71. [DOI: 10.1200/jco.2005.02.774] [Cited by in Crossref: 104] [Cited by in F6Publishing: 108] [Article Influence: 5.8] [Reference Citation Analysis]
53 Akouaouach H, Mortaki A, Pepersack T. A typical case of Sezary syndrome mimicking an eczema. Acta Clin Belg 2005;60:13-6. [PMID: 15981699 DOI: 10.1179/acb.2005.004] [Reference Citation Analysis]
54 Whittaker SJ, Marsden JR, Spittle M, Russell Jones R. Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas. Br J Dermatol. 2003;149:1095-1107. [PMID: 14696593 DOI: 10.1111/j.1365-2133.2003.05698.x] [Cited by in Crossref: 172] [Cited by in F6Publishing: 182] [Article Influence: 9.1] [Reference Citation Analysis]
55 Ingen-housz-oro S, Bachelez H, Verola O, Lebbé C, Marolleau JP, Hennequin C, Dubertret L, Morel P, Gisselbrecht C, Brice P. High-dose therapy and autologous stem cell transplantation in relapsing cutaneous lymphoma. Bone Marrow Transplant 2004;33:629-34. [DOI: 10.1038/sj.bmt.1704411] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.3] [Reference Citation Analysis]
56 Oyama Y, Guitart J, Kuzel TM, Burt RK, Rosen ST. High-dose therapy and bone marrow transplantation in cutaneous T-cell lymphoma. Hematology/Oncology Clinics of North America 2003;17:1475-83. [DOI: 10.1016/s0889-8588(03)00114-x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.2] [Reference Citation Analysis]
57 Soligo D, Ibatici A, Berti E, Morandi P, Longhi E, Venegoni L, Corbellino M, Annaloro C, Robbiolo L, Della Volpe A, Alessi E, Lambertenghi Deliliers G. Treatment of advanced mycosis fungoides by allogeneic stem-cell transplantation with a nonmyeloablative regimen. Bone Marrow Transplant 2003;31:663-6. [DOI: 10.1038/sj.bmt.1703872] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 2.9] [Reference Citation Analysis]
58 Au WY, Liang R. ziPeripheral T-cell lymphoma. Curr Oncol Rep 2002;4:434-42. [DOI: 10.1007/s11912-002-0038-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]